- Home
- BMY vs PFE Comparison
BMY vs PFE Comparison
Compare BMY & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- PFE
- Stock Information
- Founded
- BMY 1887
- PFE 1849
- Country
- BMY United States
- PFE United States
- Employees
- BMY N/A
- PFE N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- BMY Health Care
- PFE Health Care
- Exchange
- BMY Nasdaq
- PFE Nasdaq
- Market Cap
- BMY 120.5B
- PFE 139.3B
- IPO Year
- BMY N/A
- PFE N/A
- Fundamental
- Price
- BMY $59.59
- PFE $24.70
- Analyst Decision
- BMY Hold
- PFE Buy
- Analyst Count
- BMY 14
- PFE 13
- Target Price
- BMY $58.00
- PFE $31.92
- AVG Volume (30 Days)
- BMY 12.2M
- PFE 57.7M
- Earning Date
- BMY 04-24-2025
- PFE 04-29-2025
- Dividend Yield
- BMY 4.16%
- PFE 6.96%
- EPS Growth
- BMY N/A
- PFE 284.33
- EPS
- BMY N/A
- PFE 1.41
- Revenue
- BMY $48,300,000,000.00
- PFE $63,627,000,000.00
- Revenue This Year
- BMY N/A
- PFE $0.10
- Revenue Next Year
- BMY N/A
- PFE N/A
- P/E Ratio
- BMY N/A
- PFE $17.49
- Revenue Growth
- BMY 7.32
- PFE 6.84
- 52 Week Low
- BMY $39.35
- PFE $24.31
- 52 Week High
- BMY $63.33
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- BMY 50.17
- PFE 36.08
- Support Level
- BMY $58.23
- PFE $25.50
- Resistance Level
- BMY $61.64
- PFE $25.43
- Average True Range (ATR)
- BMY 1.45
- PFE 0.48
- MACD
- BMY -0.16
- PFE -0.14
- Stochastic Oscillator
- BMY 39.74
- PFE 17.46
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.